Francesca Romana Mancini

ORCID: 0000-0003-2297-3869 · 4 papers in corpus
2019
Development and validation of circulating CA125 prediction models in postmenopausal women.
Journal of ovarian research ·doi:10.1186/s13048-019-0591-4

BackgroundCancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal charac…

other 2019
Predicting Circulating CA125 Levels among Healthy Premenopausal Women
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.EPI-18-1120

BACKGROUND: Cancer antigen 125 (CA125) is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, thi…

article 2017
Cervical mucus proteome in endometriosis
Clinical proteomics ·doi:10.1186/s12014-017-9142-4

BACKGROUND: Endometriosis is a chronic gynecological inflammatory disease characterized by the presence of functional endometrial glands and stroma outside of the uterine cavity. It affects 7-10% of women of reproductive age and up to 50% o…

2014
Exposure to endocrine disrupters and nuclear receptor gene expression in infertile and fertile women from different Italian areas.
International journal of environmental research and public health ·doi:10.3390/ijerph111010146

Within the PREVIENI project, infertile and fertile women were enrolled from metropolitan, urban and rural Italian areas. Blood/serum levels of several endocrine disrupters (EDs) (perfluorooctane sulfonate, PFOS; perfluorooctanoic acid, PFOA…